EP3240554
Blautia stercoris og wexlerae til notkunar við að meðhöndla bólgu- og sjálfsofnæmissjúkdóma
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
15.6.2016EP published:
31.7.2019EP application number:
16731640.5
EP translation filed:
22.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
14.6.2036Expiry date:
14.6.2023
Title:
BLAUTIA STERCOSIS AND WEXLERAE FOR USE IN TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
Timeline
Today
15.6.2016EP application
31.7.2019EP Publication
22.10.2019Translation submitted
15.11.2019Registration published
14.6.2023Expires
Owner
Name:
4D Pharma Research LimitedAddress:
Life Sciences Innovation Building Cornhill Road, Aberdeen, Aberdeenshire AB25 2ZS, GB
Inventor
Name:
GRANT, GeorgeAddress:
AberdeenAberdeenshire AB25 2ZS, GB
Name:
PATTERSON, Angela MargaretAddress:
NorwichEast Anglia NR4 7JT, GB
Name:
MULDER, ImkeAddress:
AberdeenAberdeenshire AB25 2ZS, GB
Name:
MCCLUSKEY, SeaninAddress:
LeedsWest Yorkshire LS1 2JZ, GB
Name:
RAFTIS, EmmaAddress:
LeedsWest Yorkshire LS1 2JZ, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201510466Date:
15.6.2015Country:
GB
Number:
201520508Date:
20.11.2015Country:
GB
Number:
201606810Date:
19.4.2016Country:
GB
Classification
Categories:
A61K 35/74, C12N 1/20, A61P 1/00, A61P 11/06, A61P 29/00, A61P 19/02, A61P 25/28, A61K 35/745
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 5.5.2020
Expires: 14.6.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 11.5.2021
Expires: 14.6.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 6.5.2022
Expires: 14.6.2023
Payer: Árnason Faktor ehf.